Search details
1.
Cancer management during the COVID-19 world pandemic.
Cancer Immunol Immunother
; 72(11): 3427-3444, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37642709
2.
An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer.
Int J Mol Sci
; 24(2)2023 Jan 16.
Article
in English
| MEDLINE | ID: mdl-36675313
3.
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications.
Int J Mol Sci
; 24(11)2023 Jun 02.
Article
in English
| MEDLINE | ID: mdl-37298642
4.
A Case-Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection.
Int J Mol Sci
; 24(10)2023 May 10.
Article
in English
| MEDLINE | ID: mdl-37239866
5.
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets.
Int J Mol Sci
; 24(16)2023 Aug 09.
Article
in English
| MEDLINE | ID: mdl-37628785
6.
High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1-actin Complex as a New Potential Target for Therapy.
Int J Mol Sci
; 23(8)2022 Apr 08.
Article
in English
| MEDLINE | ID: mdl-35456960
7.
Plasma Circular RNAs as Biomarkers for Breast Cancer.
Biomedicines
; 12(4)2024 Apr 16.
Article
in English
| MEDLINE | ID: mdl-38672229
8.
The effect of mindfulness-based interventions on biomarkers in cancer patients and survivors: A systematic review.
Stress Health
; : e3375, 2024 Jan 23.
Article
in English
| MEDLINE | ID: mdl-38259050
9.
In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.
Pharmaceutics
; 16(5)2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38794326
10.
The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblasts.
Hematol Oncol
; 31(2): 110-6, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-22930480
11.
Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches.
Pharmaceutics
; 15(4)2023 Apr 15.
Article
in English
| MEDLINE | ID: mdl-37111734
12.
An Overview of siRNA Delivery Strategies for Urological Cancers.
Pharmaceutics
; 14(4)2022 Mar 27.
Article
in English
| MEDLINE | ID: mdl-35456552
13.
Impact of psychosocial, behavioral and lifestyle factors on subjective cognitive complaints and perceived quality of life in a large cohort of Italian breast cancer patients.
Front Psychol
; 13: 1015573, 2022.
Article
in English
| MEDLINE | ID: mdl-36438336
14.
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials.
Cancer Treat Rev
; 109: 102429, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35759856
15.
Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules.
Pharmaceuticals (Basel)
; 14(8)2021 Aug 16.
Article
in English
| MEDLINE | ID: mdl-34451900
16.
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer.
J Control Release
; 330: 1132-1151, 2021 02 10.
Article
in English
| MEDLINE | ID: mdl-33212117
17.
Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer.
World J Clin Oncol
; 11(7): 450-463, 2020 Jul 24.
Article
in English
| MEDLINE | ID: mdl-32821651
18.
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells.
Int J Pharm
; 574: 118895, 2020 Jan 25.
Article
in English
| MEDLINE | ID: mdl-31862491
19.
Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder cancer.
Front Oncol
; 14: 1391466, 2024.
Article
in English
| MEDLINE | ID: mdl-38496760
20.
Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.
PLoS One
; 14(12): e0227068, 2019.
Article
in English
| MEDLINE | ID: mdl-31856204